Company Profile

Founded in 2000 out of the laboratory of Professor Michael Sefton at the University of Toronto, the Theramer^® company develops advanced medical polymers that look beyond the advent of combination products (e.g., drug-eluting devices). Theramers^® are polymers that will give devices drug-like properties - without the drugs. We are located in Toronto’s Discovery District in one of the world’s largest health network centres. Rimon Therapeutics aims to be a leader in the biomaterials, medical device, and regenerative medicine industries, incorporating its Theramer^® technology into medical products worldwide.

Rimon’s team is supported by a strong Board of Directors with proven business experience and a Scientific Advisory Network composed of world-renowned scientists and business leaders.

We are focused on novel Theramer^®-based products and enhancing current medical devices that address large markets with significant unmet needs.

We are the Theramer^® Company - our growing company and team provide the medical device industry with advanced Theramer^® biomaterials that address a broad range of medical disorders.
Dr. Michael H. May, PhD, President, Director